Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Jobs Report Hits 200K, Unemployment 4.1%; Plus More Q4 Earnings

Published 02/01/2018, 10:31 PM
Updated 07/09/2023, 06:31 AM

Friday, February 2, 2018

Happy Groundhog Day! As we see on the first Friday of almost every month, new non-farm payrolls from the Bureau of Labor Statistics (BLS) have been released before the opening bell. This comes in conjunction with tonnage of new Q4 earnings reports both after yesterday’s market close and before today’s open. The headline was better than expected, but not a huge surprise: 200K new jobs created in January, with an Unemployment Rate remaining steady at 4.1%.

While this 200K number is higher than the analyst consensus of roughly 180K (analyst for months have been expecting 180K new jobs), it is below the ADP (NASDAQ:ADP) payroll report released Wednesday morning, which showed 234K new jobs in just the private sector alone. Typically, however, while the ADP and BLS numbers do tend to align with future revisions, initially they are often far apart from one another.

Pre-market trading, which had been deep in the red ahead of the BLS announcement, clawed back to around -180 points on the Dow, only to plummet back to around -225 points following the news. Since that time, in the last 15 minutes or so, markets have again worked to climb out of its early hole. Meanwhile, the 10-year t-bill races up past 2.8% following the release of the jobs data.

Not that there is anything to particularly grieve in today’s jobs report: Construction posted the biggest improvement of any sector compared to a year ago, at 36K new jobs. And the U-6 (aka “real unemployment”) fell to 8.2%, the lowest we’ve seen in quite some time. Otherwise, these figures came in much as expected, aside from the predicted 4.1% unemployment rate, Average Hourly Earnings was again a positive, if tepid, +0.3% (2.9% year over year) and a consistent Labor Force Participation Rate of 62.7%.

Finally, December’s BLS totals were revised upward, from 148K to 160K. This is slightly offset by November’s revision, to 216K from the 252K originally announced.

Q4 Earnings Roundup

Following yesterday afternoon’s modest beat from Apple (NASDAQ:AAPL) , Amazon’s (NASDAQ:AMZN) biggest profit in history and Alphabet’s (NASDAQ:GOOGL) earnings miss on tax adjustment, before today’s bell bring another full load of earnings reports:

ExxonMobil (NYSE:XOM) missed both top- and bottom-line estimates, bringing in 88 cents per share ($1.04 for the Zacks consensus) on $66.5 billion in revenues ($74.4 billion expected). The Zacks Rank #3 (Hold) company has now missed earnings estimates in 2 of the last 5 quarters. For more on XOM’s earnings, click here.

Phillips 66 (NYSE:PSX) , a downstream oil & gas play, easily topped expectations for its quarter: $1.07 per share outpaced the 86 cents anticipated, with $30.12 billion far ahead of the $23.67 billion in the Zacks consensus. For more on PSX’s earnings, click here.

Estee Lauder (NYSE:EL) also surpassed expectations with $1.52 per share and $3.74 billion in revenues beating the $1.44 per share and $3.67 billion we were looking for. The quarter was assisted by double-digit growth in Skincare, Makeup and Fragrance categories. For more on EL’s earnings, click here.

Merck (NYSE:MRK) topped estimates by 4 cents to 98 cents per share, while coming up short on revenue estimates: $10.43 billion as opposed to the $10.49 billion expected. Generic competition has affected the Big Pharma Dow component’s quarter. For more on MRK’s earnings, click here.

And Merck’s competitor AstraZeneca (NYSE:AZN) also faced generic competition for some of its top-selling drugs, but managed to top earnings and revenue expectations: 65 cents per share outperformed by 20 cents, whereas $5.78 billion in sales easily beat the $5.59 billion anticipated. For more on AZN’s earnings, click here.

Mark Vickery
Senior Editor

Questions or comments about this article and/or its author? Click here>>

Zacks’ Best Private Investment Ideas

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public.

Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors.

Click here for Zacks' private trades >>



Amazon.com, Inc. (AMZN): Free Stock Analysis Report

Alphabet Inc. (GOOGL): Free Stock Analysis Report

Astrazeneca PLC (LON:AZN

Merck & Company, Inc. (MRK): Free Stock Analysis Report

Apple Inc. (AAPL): Free Stock Analysis Report

Estee Lauder Companies, Inc. (The) (EL): Free Stock Analysis Report

Phillips 66 (PSX): Free Stock Analysis Report

Exxon Mobil Corporation (XOM): Free Stock Analysis Report

Automatic Data Processing, Inc. (ADP): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.